Drug Development stands as a complex yet crucial process, ushering new medications from conception through rigorous research, preclinical testing, clinical trials, and regulatory approvals. This collaborative journey involves researchers, pharmaceutical companies, and regulatory bodies to ensure the safety and efficacy of novel drugs. The landscape of Drug Development includes targeted therapies, biopharmaceuticals, and precision medicine, striving to tailor treatments to individual patient profiles. Technological innovations like high-throughput screening and bioinformatics expedite the discovery of therapeutic agents. As a cornerstone of medical progress, Drug Development plays a pivotal role in addressing unmet medical needs, advancing healthcare, and improving patient outcomes. Key terms associated with Drug Development include preclinical trials, clinical phases, pharmacology, regulatory approvals, and pharmaceutical research. Drug development is conducted under strict ethical and regulatory guidelines to protect patient welfare and ensure the integrity of scientific research. Regulatory compliance is paramount to gaining approvals and maintaining public trust.
Title : The power of presence: Investing in LVNs for lasting impact
Emma Gitomer, Houston Methodist Hospital, United States
Title : Reaching our residents: An interdisciplinary approach to educating our future providers in the art of telephone triage
Cori Brown, Childrens Hospital of Philadelphia, United States
Title : Turn the heat around: Quality improvement in malignant hyperthermia response through in-situ simulation
Ayumi S Fielden, Houston Methodist Hospital, United States
Title : PTSD and tools for nursing resilience
Renee Bauer, Indiana State University, United States
Title : Birth partnerships: Enhancing nursing care with doula support
Vera Kevic, Doulas on Bikes, Canada
Title : Shift strong: A proactive stress-physiology framework for early identification of nurse distress
Laura Hall, Colorado Mesa University, United States